SCHEMBL8209065

SCHEMBL8209065

CC(NC(=O)OCc1ccccc1)[C@@H]1C[C@@H]2c3cccc4c3c(cn4C)C[C@H]2N(C)C1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 5/20 0.71
HTR2B P41595 5/20 0.71
MEN1 O00255 3/20 0.71
KMT2A Q03164 3/20 0.71
USP2 O75604 3/20 0.71
HTR7 P34969 3/20 0.71
HTR6 P50406 3/20 0.71
HTR2A P28223 3/20 0.71
CYP1A2 P05177 3/20 0.71
RGS12 O14924 3/20 0.71
GNAI1 P63096 3/20 0.71
KDM4E B2RXH2 3/20 0.71
ALDH1A1 P00352 3/20 0.71
TP53 P04637 2/20 0.71
CYP3A4 P08684 2/20 0.71
MAPT P10636 2/20 0.71
TSHR P16473 2/20 0.71
CYP2C19 P33261 2/20 0.71
TDP1 Q9NUW8 2/20 0.71
LMNA P02545 2/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11321615 0.87 CYP2D6 (0.67) CYP2D6HTR2BMEN1KMT2AUSP2
SCHEMBL11321610 0.87 CYP2D6 (0.67) CYP2D6HTR2BMEN1KMT2AUSP2
SCHEMBL8211853 0.84 HTR7 (0.71) CYP2D6HTR2BMEN1KMT2AUSP2
Metergoline SCHEMBL117882 0.83 HTR2B (1.00) CYP2D6HTR2BMEN1KMT2AUSP2
Metergoline SCHEMBL15440536 0.83 HTR2B (1.00) CYP2D6HTR2BMEN1KMT2AUSP2
Metergoline SCHEMBL29392365 0.83 HTR2B (1.00) CYP2D6HTR2BMEN1KMT2AUSP2
Metergoline SCHEMBL19236127 0.83 HTR2B (1.00) CYP2D6HTR2BMEN1KMT2AUSP2
Metergoline SCHEMBL7631854 0.83 HTR2B (1.00) CYP2D6HTR2BMEN1KMT2AUSP2
SCHEMBL8209067 0.82 HTR2B (0.84) CYP2D6HTR2BMEN1KMT2AUSP2
SCHEMBL11724011 0.81 HTR2B (0.80) CYP2D6HTR2BMEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6026817-A ADMINISTERING OPIATE ANTAGONIST BEFORE THERAPIC DRUG NEURENDO PHARMA, LLC 2000-02-22 US disclosed